This presentation will discuss the myriad of ways in which the June 2016 amendments to the Toxic Substances Control Act will affect how companies conduct science that may be submitted to EPA under TSCA. It will provide an overview of the key changes to TSCA, then address in detail several aspects of those changes that affect how companies meet their obligations and embrace their opportunities under the new TSCA.

Among the issues are the obligations on EPA to meet new standards of good science; the opportunities those obligations create for companies potentially affected by EPA decisions; the expected increase in testing requirements imposed on manufacturers; the incentives for companies to conduct testing even if not required by EPA; the development of alternatives to animal testing; and the importance of analytical chemistry to TSCA compliance and protection of confidential chemical identities.